Mark J Enyedy Charles River Laboratories International, Inc. (CRL) insider trading activity

CRL Quotes by TradingView

Mark J Enyedy is Director of CHARLES RIVER LABORATORIES INTERNATIONAL, INC.. Currently has a direct ownership of 946 shares of CRL, which is worth approximately $142,846. The most recent transaction as insider was on Jun 02, 2025, when has been sold 946 shares (Common Stock) at a price of $135.04 per share, resulting in proceeds of $127,747. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 946
n/a 3M change
n/a 12M change
Total Value Held $142,846

Mark J Enyedy Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 02 2025
BUY
Grant, award, or other acquisition
$127,747 $135.04 p/Share
946 Added 50.0%
946 Common Stock

Also insider at

LOGC
LogicBio Therapeutics, Inc. Healthcare
Director
IMGN
ImmunoGen, Inc. Healthcare
CHIEF EXECUTIVE OFFICER
BMRN
BIOMARIN PHARMACEUTICAL INC Healthcare
Director
MJE

Mark J Enyedy

Director
Waltham, MA

Track Institutional and Insider Activities on CRL

Follow CHARLES RIVER LABORATORIES INTERNATIONAL, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRL shares.

Notify only if

Insider Trading

Get notified when an Charles River Laboratories International, Inc. insider buys or sells CRL shares.

Notify only if

News

Receive news related to CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CRL